"Influenza B virus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Species of the genus INFLUENZAVIRUS B that cause HUMAN INFLUENZA and other diseases primarily in humans. Antigenic variation is less extensive than in type A viruses (INFLUENZA A VIRUS) and consequently there is no basis for distinct subtypes or variants. Epidemics are less likely than with INFLUENZA A VIRUS and there have been no pandemics. Previously only found in humans, Influenza B virus has been isolated from seals which may constitute the animal reservoir from which humans are exposed.
| Descriptor ID |
D009981
|
| MeSH Number(s) |
B04.820.545.407.410
|
| Concept/Terms |
Influenza B virus- Influenza B virus
- Influenza B viruses
- Orthomyxoviruses Type B
- Influenza Viruses Type B
|
Below are MeSH descriptors whose meaning is more general than "Influenza B virus".
Below are MeSH descriptors whose meaning is more specific than "Influenza B virus".
This graph shows the total number of publications written about "Influenza B virus" by people in this website by year, and whether "Influenza B virus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 0 | 2 |
| 1998 | 0 | 2 | 2 |
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 1 | 2 |
| 2002 | 1 | 0 | 1 |
| 2003 | 3 | 0 | 3 |
| 2004 | 3 | 0 | 3 |
| 2006 | 2 | 0 | 2 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 1 | 2 |
| 2010 | 2 | 1 | 3 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2015 | 2 | 2 | 4 |
| 2016 | 0 | 3 | 3 |
| 2017 | 2 | 3 | 5 |
| 2018 | 2 | 2 | 4 |
| 2019 | 1 | 4 | 5 |
| 2020 | 1 | 2 | 3 |
| 2021 | 1 | 6 | 7 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 3 | 3 |
| 2024 | 1 | 2 | 3 |
| 2025 | 1 | 4 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Influenza B virus" by people in Profiles.
-
Influenza Vaccine Effectiveness Against Medically Attended Outpatients Illness, United States, 2023-2024 Season. Clin Infect Dis. 2025 Nov 06; 81(4):e184-e191.
-
Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations, United States, 1 September 2023 to 31 May 2024. J Infect Dis. 2025 Oct 15; 232(4):e626-e636.
-
Antiviral Use Among Children Hospitalized With Laboratory-Confirmed Influenza Illness: A Prospective, Multicenter Surveillance Study. Clin Infect Dis. 2025 Oct 06; 81(3):623-633.
-
Influenza-Associated Acute Necrotizing Encephalopathy in US Children. JAMA. 2025 08 26; 334(8):692-701.
-
Pediatric Clinical Influenza Disease by Type and Subtype 2015-2020: A Multicenter, Prospective Study. J Pediatric Infect Dis Soc. 2025 Jan 20; 14(1).
-
Reduced Effectiveness of Repeat Influenza Vaccination: Distinguishing Among Within-Season Waning, Recent Clinical Infection, and Subclinical Infection. J Infect Dis. 2024 Dec 16; 230(6):1309-1318.
-
Isolation of human antibodies against influenza B neuraminidase and mechanisms of protection at the airway interface. Immunity. 2024 06 11; 57(6):1413-1427.e9.
-
Vaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023. Clin Infect Dis. 2024 04 10; 78(4):1056-1064.
-
Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021-2022 Influenza Season. Clin Infect Dis. 2023 04 17; 76(8):1358-1363.
-
Influenza Vaccine Effectiveness Among Children: 2011-2020. Pediatrics. 2023 04 01; 151(4).